IRIS Accounts Production v24.2.0.383 12896990 Board of Directors 1.7.23 30.6.24 30.6.24 false true false false true false Ordinary A 1.00000 Ordinary B 1.00000 Ordinary D 1.00000 iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh128969902023-06-30128969902024-06-30128969902023-07-012024-06-30128969902022-06-30128969902022-07-012023-06-30128969902023-06-3012896990ns15:EnglandWales2023-07-012024-06-3012896990ns14:PoundSterling2023-07-012024-06-3012896990ns10:Director12023-07-012024-06-3012896990ns10:PrivateLimitedCompanyLtd2023-07-012024-06-3012896990ns10:SmallEntities2023-07-012024-06-3012896990ns10:AuditExempt-NoAccountantsReport2023-07-012024-06-3012896990ns10:SmallCompaniesRegimeForDirectorsReport2023-07-012024-06-3012896990ns10:SmallCompaniesRegimeForAccounts2023-07-012024-06-3012896990ns10:AbridgedAccounts2023-07-012024-06-3012896990ns10:OrdinaryShareClass12023-07-012024-06-3012896990ns10:OrdinaryShareClass22023-07-012024-06-3012896990ns10:OrdinaryShareClass32023-07-012024-06-3012896990ns10:Director22023-07-012024-06-3012896990ns10:Director32023-07-012024-06-3012896990ns10:CompanySecretary12023-07-012024-06-3012896990ns10:RegisteredOffice2023-07-012024-06-3012896990ns5:CurrentFinancialInstruments2024-06-3012896990ns5:CurrentFinancialInstruments2023-06-3012896990ns5:ShareCapital2024-06-3012896990ns5:ShareCapital2023-06-3012896990ns5:SharePremium2024-06-3012896990ns5:SharePremium2023-06-3012896990ns5:RetainedEarningsAccumulatedLosses2024-06-3012896990ns5:RetainedEarningsAccumulatedLosses2023-06-3012896990ns10:OrdinaryShareClass12024-06-3012896990ns10:OrdinaryShareClass22024-06-3012896990ns10:OrdinaryShareClass32024-06-30
REGISTERED NUMBER: 12896990 (England and Wales)












UNAUDITED FINANCIAL STATEMENTS

FOR THE YEAR ENDED 30 JUNE 2024

FOR

WARWICK SAS MEDICAL LIMITED

WARWICK SAS MEDICAL LIMITED (REGISTERED NUMBER: 12896990)






CONTENTS OF THE FINANCIAL STATEMENTS
for the year ended 30 June 2024




Page

Company Information 1

Abridged Balance Sheet 2

Notes to the Financial Statements 4


WARWICK SAS MEDICAL LIMITED

COMPANY INFORMATION
for the year ended 30 June 2024







DIRECTORS: D F Booth
Mrs A S Green
Dr C A Robertson



SECRETARY: Mrs A S Green



REGISTERED OFFICE: Warwick House
Heathcote Way
Warwick
Warwickshire
CV34 6TE



REGISTERED NUMBER: 12896990 (England and Wales)



BANKERS: Lloyds Bank Plc
22 Bridge Street
Stratford-upon-Avon
Warwickshire

WARWICK SAS MEDICAL LIMITED (REGISTERED NUMBER: 12896990)

ABRIDGED BALANCE SHEET
30 June 2024

2024 2023
Notes £    £    £    £   
FIXED ASSETS
Investments 4 3,200,008 3,200,008

CURRENT ASSETS
Debtors 544,689 467,580
Cash at bank 57,596 20,067
602,285 487,647
CREDITORS
Amounts falling due within one year 383,138 293,550
NET CURRENT ASSETS 219,147 194,097
TOTAL ASSETS LESS CURRENT
LIABILITIES

3,419,155

3,394,105

CAPITAL AND RESERVES
Called up share capital 5 203 203
Share premium 3,199,805 3,199,805
Retained earnings 219,147 194,097
SHAREHOLDERS' FUNDS 3,419,155 3,394,105

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 30 June 2024.

The members have not required the company to obtain an audit of its financial statements for the year ended 30 June 2024 in accordance with Section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

WARWICK SAS MEDICAL LIMITED (REGISTERED NUMBER: 12896990)

ABRIDGED BALANCE SHEET - continued
30 June 2024


The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

All the members have consented to the preparation of an abridged Balance Sheet for the year ended 30 June 2024 in accordance with Section 444(2A) of the Companies Act 2006.

In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered.

The financial statements were approved by the Board of Directors and authorised for issue on 3 October 2024 and were signed on its behalf by:





D F Booth - Director


WARWICK SAS MEDICAL LIMITED (REGISTERED NUMBER: 12896990)

NOTES TO THE FINANCIAL STATEMENTS
for the year ended 30 June 2024

1. STATUTORY INFORMATION

Warwick SAS Medical Limited is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

2. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with the provisions of Section 1A "Small Entities" of Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" and the Companies Act 2006.

The financial statements are presented in sterling which is the functional currency of the company and is rounded to the nearest £1.

Preparation of consolidated financial statements
The financial statements contain information about Warwick SAS Medical Limited as an individual company and do not contain consolidated financial information as the parent of a group. The company is exempt under Section 399(2A) of the Companies Act 2006 from the requirements to prepare consolidated financial statements.

Investments in subsidiaries
Investments in subsidiary undertakings are recognised at cost.

3. EMPLOYEES AND DIRECTORS

The average number of employees during the year was 3 (2023 - 3 ) .

4. FIXED ASSET INVESTMENTS

Information on investments other than loans is as follows:
Totals
£   
COST
At 1 July 2023
and 30 June 2024 3,200,008
NET BOOK VALUE
At 30 June 2024 3,200,008
At 30 June 2023 3,200,008

5. CALLED UP SHARE CAPITAL

Allotted, issued and fully paid:
Number: Class: Nominal 2024 2023
value: £    £   
11,337 Ordinary A 1p 113 113
50 Ordinary B £1 50 50
40 Ordinary D £1 40 40
203 203

WARWICK SAS MEDICAL LIMITED (REGISTERED NUMBER: 12896990)

NOTES TO THE FINANCIAL STATEMENTS - continued
for the year ended 30 June 2024

6. RELATED PARTY DISCLOSURES

The company has taken advantage of exemption, under the terms of Financial Reporting Standard 102 'The Financial Reporting Standard applicable in the UK and Republic of Ireland', not to disclose related party transactions with wholly owned subsidiaries within the group.